Skip to main content

Table 1 The baseline characteristics of participants

From: Association between triglyceride-to-high density lipoprotein cholesterol ratio and three-month outcome in patients with acute ischemic stroke: a second analysis based on a prospective cohort study

TG/HDL-ratio (quartile)

Q1(< 1.435)

Q2(1.435 to 2.125)

Q3(2.125 to 3.205)

Q4(≥ 3.205)

P-value

participants

441

440

441

442

 

HGB(g/dL)

13.24 ± 1.82

13.56 ± 1.85

13.60 ± 1.93

13.64 ± 2.20

0.010

HCT(%)

39.57 ± 5.06

40.33 ± 5.19

40.44 ± 5.36

40.38 ± 6.17

0.059

MCV(fl)

93.29 ± 5.65

93.40 ± 5.28

92.92 ± 4.58

92.36 ± 5.25

0.013

PLT(10^9/L)

218.56 ± 64.95

220.64 ± 69.24

222.61 ± 69.06

236.74 ± 77.58

 < 0.001

TC(mg/dl)

176.74 ± 39.28

180.40 ± 43.62

177.46 ± 42.04

184.80 ± 46.73

0.022

TG(mg/dl)

63.77 ± 15.23

88.20 ± 16.80

109.91 ± 23.56

167.31 ± 50.97

 < 0.001

HDL-c(mg/dl)

60.28 ± 12.47

49.71 ± 9.85

42.16 ± 8.63

36.04 ± 8.03

 < 0.001

LDL-c(mg/dl)

100.10 ± 33.30

110.58 ± 38.77

111.24 ± 36.08

113.33 ± 39.41

 < 0.001

BUN(mg/dl)

15.00 (12.00–20.00)

15.00 (12.00–20.00)

16.00 (13.00–20.00)

15.00 (12.00–20.00)

0.655

Scr(mg/dl)

0.85 (0.70–1.00)

0.88 (0.73–1.08)

0.90 (0.76–1.05)

0.95 (0.76–1.16)

 < 0.001

ALT(U/L)

23.00 (19.00–29.00)

23.00 (18.00–29.00)

23.00 (19.00–29.00)

23.00 (18.00–29.75)

0.467

AST (U/L)

17.00 (13.00–24.00)

17.00 (12.75–25.00)

19.00 (14.00–26.00)

19.00 (14.00–29.00)

0.090

ALB (g/dL)

4.04 ± 0.36

4.04 ± 0.41

4.03 ± 0.43

4.00 ± 0.45

0.448

FBG(mmol/L)

5.28 (4.67–6.28)

5.44 (4.66–6.62)

5.44 (4.83–6.44)

5.44 (4.83–6.72)

0.059

FIB (mg/L)

321.96 ± 69.92

326.11 ± 78.89

333.42 ± 83.83

350.25 ± 94.70

 < 0.001

BMI (kg/m2)

22.46 ± 2.99

23.22 ± 3.19

23.85 ± 3.20

24.47 ± 3.21

 < 0.001

Sex

    

 < 0.001

 Male

224 (50.79%)

266 (60.45%)

291 (65.99%)

292 (66.06%)

 

 Female

217 (49.21%)

174 (39.55%)

150 (34.01%)

150 (33.94%)

 

Age(years)

    

0.006

 < 60

91 (20.63%)

83 (18.86%)

103 (23.36%)

118 (26.70%)

 

 60 to < 70

107 (24.26%)

120 (27.27%)

124 (28.12%)

115 (26.02%)

 

 70 to < 80

153 (34.69%)

160 (36.36%)

162 (36.73%)

154 (34.84%)

 

 ≥ 80

90 (20.41%)

77 (17.50%)

52 (11.79%)

55 (12.44%)

 

Previous stroke/TIA

91 (20.63%)

97 (22.05%)

89 (20.18%)

92 (20.81%)

0.917

Hypertension

261 (59.18%)

282 (64.09%)

284 (64.40%)

289 (65.38%)

0.222

DM

106 (24.04%)

135 (30.68%)

147 (33.33%)

163 (36.88%)

 < 0.001

Smoking

120 (27.21%)

166 (37.73%)

202 (45.80%)

213 (48.19%)

 < 0.001

CHD

39 (8.84%)

55 (12.50%)

55 (12.47%)

54 (12.22%)

0.249

Stroke etiology

    

 < 0.001

 SVO

80 (18.14%)

90 (20.45%)

86 (19.50%)

87 (19.68%)

 

 LAA

124 (28.12%)

136 (30.91%)

145 (32.88%)

169 (38.24%)

 

 CE

142 (32.20%)

119 (27.05%)

103 (23.36%)

84 (19.00%)

 

 Other determined

23 (5.22%)

39 (8.86%)

48 (10.88%)

38 (8.60%)

 

 Undetermined

72 (16.33%)

56 (12.73%)

59 (13.38%)

64 (14.48%)

 

NIHSS score

    

0.273

 < 6

285 (64.63%)

306 (69.55%)

303 (68.71%)

315 (71.27%)

 

 6 to 13

93 (21.09%)

82 (18.64%)

93 (21.09%)

84 (19.00%)

 

  ≥ 14

63 (14.29%)

52 (11.82%)

45 (10.20%)

43 (9.73%)

 
  1. Values are mean ± standard deviation or median (quartile) or number (%)
  2. HGB Hemoglobin concentration, HCT Hematocrit, MCV Mean corpuscular volume, PLT Platelet, TG Triglyceride, TC Total cholesterol, HDL-c High-density lipoprotein cholesterol, LDL-c Low-density lipoproteins cholesterol, BUN Blood urea nitrogen, Scr Serum creatinine, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ALB Serum albumin, FBG Fasting blood glucose, FIB Fibrinogen, BMI body mass index, DM Diabetes mellitus, CHD Coronary heart disease, TIA Transient ischemia attack. LAA Large artery atherosclerosis, SVO Small vessel occlusion, CE Cardio embolism, NIHSS National institute of health stroke scale, TG/HDL Ratio, triglyceride -to- high density lipoprotein cholesterol ratio
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us